Pharmaceutical Product Information
Tarceva® (erlotinib)
Please be informed that Roche has divested Tarceva Tablet 150mg (SIN13184P) and 100 mg (SIN13185P) globally to CHEPLAPHARM Schweiz GmbH, Switzerland. For more detailed information, please refer to the below attached Customer Notification Letter.
Healthcare Professionals
Product Information (PI)
Customer Notification Letter
Should you face issues with accessing the product information, please contact us via tel: +65-6735 0550or click here
Solutions